Featured Research

from universities, journals, and other organizations

Elucidating side effects of antineoplastic agent

Date:
October 5, 2010
Source:
CNRS (Délégation Paris Michel-Ange)
Summary:
Cisplatin, an anticancer drug widely used for treating various types of tumor, can induce side effects in the short term. A team of scientists has provided first in vitro evidence that this antitumor agent modifies the sensitivity of cellular pressure sensors. This completely novel mechanism could help to elucidate certain neurological side effects of cisplatin hitherto unexplained. These results could open potential avenues for improving the chemotherapeutic efficacy of cisplatin-based compounds. The researchers now plan to test them on animal models.

Cisplatin, an anticancer drug widely used for treating various types of tumor, can induce side effects in the short term. A team of scientists, mostly from CNRS and the Université de Nice, has provided first in vitro evidence that this antitumor agent modifies the sensitivity of cellular pressure sensors. This completely novel mechanism could help to elucidate certain neurological side effects of cisplatin hitherto unexplained. These results could open potential avenues for improving the chemotherapeutic efficacy of cisplatin-based compounds. The researchers now plan to test them on animal models.

Their work was published October 1, 2010 in the journal Cancer Research.

Cisplatin is a platinum-based molecule widely used in the treatment of various forms of cancer in humans. Following intravenous administration, it penetrates the cells to form stable complexes with the DNA molecule, thereby preferentially killing tumor cells, which are the most vulnerable. In order to proliferate, cancer cells actually need to constantly replicate their DNA, which they can no longer do when it is complexed with cisplatin. However, this treatment has a major drawback. Within an hour or even half an hour following injection, some patients suffer from side effects: perception and hearing disorders, tinnitus and sometimes inner ear dysfunctions causing dizziness. The unpleasantness of these neurological effects can prompt patients to interrupt the treatment, despite its efficacy. A better understanding of these short-term side effects is therefore crucial.

Most research laboratories mainly focus on cisplatin's action on DNA. However, such genotoxic effects cannot occur very rapidly: consequently, they do not explain the short-term side effects of cisplatin and other antineoplastic drugs of the same family. For this reason, the team of scientists headed by Laurent Counillon and Mallorie Poët, researchers at the Institut de Pharmacologie Moléculaire et Cellulaire (CNRS/Université de Nice) decided to focus on another aspect of cisplatin: its already known action at the cell membrane level.

The researchers conducted their experiments in a model cell system. They discovered that cisplatin, independently of its action on DNA, is capable of modifying, within a few minutes, the architecture of a cell membrane: injecting this molecule into a cell changes the shape, morphology and tension of its membrane. Yet, the cell membrane contains numerous pressure- and stretch-sensitive proteins. These sensors regulate the pain threshold in peripheral nerve fibers and detect sound waves and "verticality" in the vestibular system of the ear . Pursuing their investigations, the scientists managed to demonstrate that cisplatin disrupts the functioning of these mechanosensitive sensors, which may trigger neurological effects. They have identified and described a novel mechanism through which this antitumor agent acts. This process could therefore explain the occurrence of cisplatin's short-term side effects.

These results make it possible to envisage optimizing the efficacy of platinum-based anticancer treatments by combining them with compounds that reduce these short-term side effects. Researchers are now due to proceed with animal testing.

Other contributors include the Laboratoire "Adhésion et Inflammation" (Inserm/CNRS/Université Aix-Marseille 2), the Centre Commun de Microscopie Appliquée de l'Université de Nice and a team from the Université de Rennes 1.


Story Source:

The above story is based on materials provided by CNRS (Délégation Paris Michel-Ange). Note: Materials may be edited for content and length.


Journal Reference:

  1. N. Milosavljevic, C. Duranton, N. Djerbi, P. H. Puech, P. Gounon, D. Lagadic-Gossmann, M. T. Dimanche-Boitrel, C. Rauch, M. Tauc, L. Counillon, M. Poet. Nongenomic Effects of Cisplatin: Acute Inhibition of Mechanosensitive Transporters and Channels without Actin Remodeling. Cancer Research, 2010; 70 (19): 7514 DOI: 10.1158/0008-5472.CAN-10-1253

Cite This Page:

CNRS (Délégation Paris Michel-Ange). "Elucidating side effects of antineoplastic agent." ScienceDaily. ScienceDaily, 5 October 2010. <www.sciencedaily.com/releases/2010/10/101005141117.htm>.
CNRS (Délégation Paris Michel-Ange). (2010, October 5). Elucidating side effects of antineoplastic agent. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2010/10/101005141117.htm
CNRS (Délégation Paris Michel-Ange). "Elucidating side effects of antineoplastic agent." ScienceDaily. www.sciencedaily.com/releases/2010/10/101005141117.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) — The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) — Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) — America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) — A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:  

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile iPhone Android Web
          Follow Facebook Twitter Google+
          Subscribe RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins